Referencias

  1. Kaye D. Endocarditis infecciosa. En: Fauci A, Braunwald E, Isselbacher K, Wilson J, Martin J, Kasper D, Hauser S, Longo D, editores. Harrison: Principios de Medicina Interna vol 1. 14 ed. cap 126, México: McGraw-Hill Interamericana; 1998. p. 896-903.
  2. Smith JA: Endocarditis infecciosa. En: Stein JH, editor. Medicina Interna: Diagnóstico y Tratamiento, 3 ed. Argentina: Editorial Médica Panamericana; 1995. p. 307-12.
  3. Smith CS: Endocarditis infecciosa. En: Dugdale DC, Eisenberg MS, editores. Diagnóstico Médico, 1 ed. cap 67, México: Interamericana McGraw-Hill; 1994. p. 714-26.
  4. Bayer AS, Scheld WM:Endocarditis and intravascular infections. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett´s Principles and practice of infectious diseases vol 1. 5th ed. ch 65, New York: Churchill Livingstone Inc.; 2000. p. 857-902.
  5. Proenca R, Serrano A, Martins T, Machado J, Maltez F, Coutinho F, et al:Infective endocarditis. Acta Med Port 1999;12(12):381-6. Portuguese.
  6. Tokuda Y, Matsumoto M, Sugita T, Yoshimura S: Methicillin-resistant Staphylococcus aureus endocarditis following repair of tetralogy of Fallot. Pediatr Cardiol 2002;23(5):564-5.
  7. Melki I, Nabbout R, Nasnas R, Akatcherian C: Right-sided endocarditis caused by Staphylococcus aureus during the neonatal period. (A case report). J Med Liban 1993;41(2):90-4. French.
  8. Gabriel Botella F, Labios Gomez M, Balaguer Martinez JV, Vera Sempere G, Tormo Diaz M, Roda Ribera J: Infectious endocarditis in parenteral drug addicts: study of 57 cases. An Med Interna 1992;9(10):473-7.
  9. Ben Mansour EH, Jacob E, Monchi M, Ledoux D, Canivet JL, De Mol P, et al: Occurrence of MRSA endocarditis during linezolid treatment. Eur J Clin Microbiol Infect Dis 2003;22:372-3.
  10. Caputo GM, Archer GL, Calderwood SB, DiNubile MJ, Karchmer AW: Native valve endocarditis due to coagulase-negative staphylococci. Clinical and microbiologic features. Am J Med 1987;83(4):619-25.
  11. Chabanier A, Bontemps T, Tardieu A, Virot P, Blanc P, Weinbreck P, et al: Simultaneous infectious endocarditis caused by Staphylococcus epidermidis and deficient Streptococcus. Presse Med 1985;14(21):1202. French.
  12. Marcano M, Riera J, Santos J, Andrade E, Landaeta JM: Trombocitopenia fatal asociada a artritis séptica por Staphylococcus coagulasa negativa en paciente inmunosuprimida con enfermedad de Libman-Sacks. Acta Científica Venezolana 1997;48(Supl 1):184.
  13. Straus DC: Protease production by Streptococcus sanguis associated with subacute bacterial endocarditis. Infect Immun 1982;38(3):1037-45.
  14. Straus DC, Portnoy-Duran C: Neuraminidase production by a Streptococcus sanguis strain associated with subacute bacterial endocarditis. Infect Immun 1983;41(2):507-15.
  15. Smith JP, Marymont JH, Schweers JH.: Subacute bacterial endocarditis due to Streptococcus mutans. Am J Med Technol 1977;43(5):429-32.
  16. Kitada K, Inoue M, Kitano M.: Infective endocarditis-inducing abilities of "Streptococcus milleri" group. Adv Exp Med Biol 1997;418:161-3.
  17. Entenza JM, Vouillamoz J, Glauser MP, Moreillon P.: Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditis. Antimicrob Agents Chemother 1999;43(1):77-84.
  18. Crawford I, Russell C.: Comparative adhesion of seven species of streptococci isolated from the blood of patients with sub-acute bacterial endocarditis to fibrin-platelet clots in vitro. J Appl Bacteriol 1986;60(2):127-33.
  19. Lopez Garcia F, Enriquez R, Amoros F, Teruel A.: Acute renal failure and leukocytoclastic vasculitis as the presenting form of infectious endocarditis caused by Streptococcus bovis. Nefrologia 2002;22(2):206-7.
  20. Kodo K, Hida M, Omori S, Mori T, Tokumura M, Kuramochi S, et al.: Vasculitis associated with septicemia: case report and review of the literature. Pediatr Nephrol 2001;16(12):1089-92.
  21. Bouvet A, van de Rijn I, McCarty M.: Nutritionally variant streptococci from patients with endocarditis: growth parameters in a semisynthetic medium and demonstration of a chromophore. J Bacteriol 1981;146(3):1075-82.
  22. Boutoille D, Reynaud AE, Leautez S, Ponge T, Raffi F.: Abiotrophia related endocarditis: contribution of molecular biology. Presse Med 1999;28(39):2149-51. French.
  23. Bouvet A.: Human endocarditis due to nutritionally variant streptococci: Streptococcus adjacens and Streptococcus defectivus. Eur Heart J 1995;16 Suppl B:S24-S7.
  24. Wasilauskas BL.: Subacute bacterial endocarditis caused by group G beta-hemolytic Streptococcus. Am J Dis Child 1977;131(12):1416-7.
  25. Benes J, Picha D, Kabelkova M, Dzupova O, Horova B, Gabrielova A.: Infective endocarditis caused by unusual gram-positive pathogens. Folia Microbiol (Praha) 2002;47(6):737-41.
  26. Uemura L, Grassi NC, Cazarin L.: Pneumococcal endocarditis of subacute evolution. Arq Bras Cardiol 2001;76(4):319-22.
  27. Taylor FE.: Subacute bacterial endocarditis due to Streptococcus fecalis (enterococcus). Va Med Mon (1918) 1967;94(1):11-5.
  28. Dietz CC, Zubrzycki LJ.: Relapses of endocarditis due to the same phage type of enterococcus. Am J Med Technol 1970;36(8):357-60.
  29. Fernandez-Guerrero ML, Herrero L, Bellver M, Gadea I, Roblas RF, de Gorgolas M. Nosocomial enterococcal endocarditis: a serious hazard for hospitalized patients with enterococcal bacteraemia. J Intern Med 2002;252(6):510-5
  30. Peset V, Cano J, Sarrion A, Perez-Belles C, Gobernado M.: Enterococcus spp. causing infectious endocarditis. Apropos of 2 cases in natural heart valves. Enferm Infecc Microbiol Clin 2002;20(3):136-7.
  31. Chunn CJ, Jones SR, McCutchan JA, Young EJ, Gilbert DN.: Haemophilus parainfluenzae infective endocarditis. Medicine (Baltimore) 1977;56(2):99-113.
  32. Gordon AM, Love WC.: Endocarditis due to Haemophilus parainfluenzae. J Med Microbiol 1970;3(3):550-4.
  33. Deleixhe M, Bardiau C, Huberlant P, Nelis E, Reginster M.: Subacute endocarditis on a prosthetic valve due to Actinobacillus actinomycetemcomitans. A new classic. Rev Med Liege 1991;46(3):123-30. French.
  34. Martin-Rico P, Martinez-Rubio C, Perez-Benito L, Sanz-Moreno J.: Subacute bacterial endocarditis caused by Cardiobacterium hominis. Enferm Infecc Microbiol Clin 1990;8(3):186.
  35. Pritchard TM, Foust RT, Cantely JR, Leman RB.: Prosthetic valve endocarditis due to Cardiobacterium hominis occurring after upper gastrointestinal endoscopy. Am J Med 1991;90(4):516-8.
  36. Brezinova L, Bigl P, Pavek V.: Eikenella corrodens as part of the polymicrobial flora in infectious endocarditis. Cesk Epidemiol Mikrobiol Imunol 1990;39(5):303-9. Czech.
  37. Giamarellou H, Galanakis N.: Use of intravenous ciprofloxacin in difficult-to-treat infections. Am J Med 1987;82(4A):346-51.
  38. Joao I, Marques P, Namora J, Aguas MJ, Rosario L, Carvalho A, et al.: Neisseria meningitidis native valve endocarditis. A case report. Rev Port Cardiol 2001;20(9):877-80. Portuguese.
  39. Tikly M, Diese M, Zannettou N, Essop R.: Gonococcal endocarditis in a patient with systemic lupus erythematosus. Br J Rheumatol 1997;36(2):270-2.
  40. Komshian SV, Tablan OC, Palutke W, Reyes MP.: Characteristics of left sided endocarditis due to Pseudomonas aeruginosa in the Detroit Medical Center. Rev Infect Dis 1990;12(4):693-702.
  41. Kochi K, Yokote Y, Kyo S, Ueda K, Omoto R.: Serratia marcescens prosthetic mitral valve endocarditis associated with hemolytic anemia. Nippon Kyobu Geka Gakkai Zasshi 1997;45(6):860-4. Japanese.
  42. Benes J, Viechova J, Kabelkova M, Horova B.: Listerial endocarditis in a penicillin-allergic woman successfully treated with a combination of 4 drugs. Scand J Infect Dis 2002;34(5):383-4.
  43. Cilla Eguiluz G, Montes Ros M, Lopez Garcia D, Iraola Sierra B, Aramburu Soraluce V.: Bartonella henselae endocarditis. Report of a case and review of the literature. An Med Interna 2001;18(5):255-8.
  44. Grand A, Celard M, el Belghiti R, Ghadban W, De Gevigney G, Dabboura A, et al.: Subacute infectious endocarditis due to the agent of cat scratch fever: Bartonella henselae. Arch Mal Coeur Vaiss 2001;94(2):157-61. French.
  45. Valero C, Farinas MC, Garcia Palomo D, Mazarrasa JC, Gonzalez Macias J.: Endocarditis due to Acinetobacter lwoffi on native mitral valve. Int J Cardiol 1999;69(1):97-9.
  46. Kunin M, Salamon F, Weinberger M, Genkin I, Sagie A, Tur-Kaspa R.: Conservative treatment of prosthetic valve endocarditis due to Mycobacterium fortuitum. Eur J Clin Microbiol Infect Dis 2002;21(7):539-41.
  47. Galil K, Thurer R, Glatter K, Barlam T.: Disseminated Mycobacterium chelonae infection resulting in endocarditis. Clin Infect Dis 1996;23(6):1322-3.
  48. Juffe A, Miranda AL, Rufilanchas JJ, Maronas JM, Figuero D.: Prosthetic valve endocarditis by opportunistic pathogens. Arch Surg 1977;112(2):151-3.
  49. Alvarez-Elcoro S, Sifuentes-Osorio J.: Clostridium perfringens bacteremia in prosthetic valve endocarditis. Diagnosis by peripheral blood smear. Arch Intern Med 1984;144(4):849-50.
  50. Palacios Hernandez HJ, Suchil L, Huerta Arias MD, Reyes PA. Infectious endocarditis caused by Candida. Presentation of 3 cases and review of the literature. Arch Inst Cardiol Mex 1987;57(3):229-33.
  51. Branco L, Pitta ML, Bernardes L, Galrinho A, Agapito AF, Ramos JM, et al. A review of infectious endocarditis due to Candida. Rev Port Cardiol 1997;16(12):967-74. Portuguese.
  52. Rubinstein E, Lang R. Fungal Endocarditis. Eur Heart J 1995;16(Suppl B):S84-S9.
  53. Satoyoshi E, Namikawa M, Namba T, Nakajima T. Aspergillus endocarditis: report of an autopsied case. Nippon Naika Gakkai Zasshi 1967;56(6):579-84. Japanese.
  54. Vázquez A, Pérez CD, Pérez H, Tena M. Miocarditis viral: Presentación de un caso. Rev Hosp Jua Mex 1997;64(3):41.
  55. Soubrane C, Bellorini M, Granier J, Haddad G, Bachet J, Le Besnerais P, et al. Q fever infectious endocarditis. Apropos of a new case. Arch Mal Coeur Vaiss 1989;82(2):265-8. French.
  56. Zamorano J, Sanz J, Almeria C, Rodrigo JL, Samedi M, Herrera D, et al. Differences between endocarditis with true negative blood cultures and those with previous antibiotic treatment. J Heart Valve Dis 2003;12(2):256-60.
  57. Al-Khuwaitir TS, Wani BA, Sherbeeni SM. Combined Brucella melitensis and streptococcal viridans endocarditis. Saudi Med J 2002;23(1):99-103.
  58. Angrist AA, Oka M. Pathogenesis of bacterial endocarditis. JAMA 1963;183:249.
  59. Komarov VT, Tatarchenko IP. Differential diagnosis of infectious and non-infectious thrombotic endocarditis. Klin Med (Mosk) 2001;79(10):17-21. Russian.
  60. Casalta JP, Habib G, La Scola B, Drancourt M, Caus T, Raoult D. Molecular diagnosis of Granulicatella elegans on the cardiac valve of a patient with culture-negative endocarditis. J Clin Microbiol 2002;40(5):1845-7.
  61. Demin AA, Sentiakova TN. Combination of Libman-Sacks endocarditis with infectious endocarditis. Klin Med (Mosk) 2002;80(3):28-33. Russian.
  62. Endocarditis infecciosa. En: Mensa J, Gatel JM, Jiménez MT, Prats G, Domínguez-Gil A, editores. Guía de Terapéutica Antimicrobiana, 11 ed. España: Masson; 2001. p. 289-93.
  63. Endocarditis infecciosa. En: Ferri FF, editor. Manual de Medicina Clínica, 1 ed. cap 15.14, México: Interamerica McGraw-Hill, 1992. p. 348-62.
  64. Michel PL, Acar J. Native cardiac disease predisposing to infective endocarditis. European Heart J 1995;16:2-6.
  65. Demin AA, Drobysheva VP, Vel'ter OIu. Infectious endocarditis in intravenous drug abusers. Klin Med (Mosk) 2000;78(8):47-51. Russian.
  66. Pena FJ, Banzo I, Quirce R, Vallina NK, Hernandez A, Guede C, Carril JM. Ga-67 SPECT to detect endocarditis after replacement of an aortic valve. Clin Nucl Med 2002;27(6):401-4.
  67. Meimoun P, Mainardi JL, Berrebi A, Choucair J, Chevalier P, Buu-Hoi A, et al. Stenotrophomonas maltophilia endocarditis following mitral valve prosthesis implantation. Report of a case. Arch Mal Coeur Vaiss 1999;92(10):1389-92. French.
  68. Clemens JD, Horwitz RI, Jaffe CC, Feinstein AR, Stanton BF. A controlled evaluation on the risk of bacterial endocarditis in persons with mitral valve prolapse. N Engl J Med 1982;307(13):776-81.
  69. MacMahon SW, Roberts JK, Kramer-Fox R, Zucker DM, Roberts RB, Devereux RB. Mitral valve prolapse and infective endocarditis. Am Heart J 1987;113(5):1291-8.
  70. Corone P, Levy A, Hallali P, Davido A, Wyler Y. A propos de 54 cas d’ endocardites infectieuses observés en 32 ans sur une population de 2038 cardiopathies congenitales. Arch Mal Coeur 1989;82:779-84. French.
  71. Ferreira A, Fernando PM, Macedo F, Capucho R. Infectious endocarditis. A form of the presentation of Marfan's syndrome--a clinical case. Rev Port Cardiol 1993;12(6):571-5, 511. Portuguese.
  72. Mokaddem A, Bachraoui K, Sdiri W, Kachboura S, Boujnah MR. Pacemaker infections. Tunis Med 2002;80(9):509-14. French.
  73. Francavilla R, Cicalini S, Massaroni K, De Rosa FG. Infective endocarditis as predisposing factor to recurrence. Recenti Prog Med 2003;94(1):12-5. Italian.
  74. Norfleet RG. Infectious endocarditis after fiberoptic sigmoidoscopy. With a literature review. J Clin Gastroenterol 1991;13(4):448-51.
  75. Pritchard TM, Foust RT, Cantely JR, Leman RB. Prosthetic valve endocarditis due to Cardiobacterium hominis occurring after upper gastrointestinal endoscopy. Am J Med 1991;90(4):516-8.
  76. Sullivan NM, Sutter VL, Mims MM, Marsh VH, Finegold SM. Clinical aspects of bacteremia after manipulation of the genitourinary tract. J Infect Dis 1973;127(1):49-55.
  77. Jansma J, Vissink A. Dental foci. Role, treatment and prophylaxis in patients at risk. Ned Tijdschr Tandheelkd 1998;105(2):52-6. Dutch.
  78. Delahaye JP, Loire R, Milon H, Durand de Gevigney G, Delahaye F, Boissonnat P, et al. Infective endocarditis on stenotic aortic valves. Eur Heart J 1988;9(Suppl E):S43-S9.
  79. Harris SL. Definitions and demographic characteristic. En: Kaye D, editor. Infective endocarditis, New York: Raven Press; 1998:1.
  80. McKinsey DS, Ratts TE, Bisno Al. Underlying cardiac lesions in adults with infective endocarditis. The changing spectrum. Am J Med 1987; 82:681-8.
  81. Garvey GJ, Neu HC. infective endocarditis: An evolving disease. Medicine (Baltimore) 1978;57:105.
  82. Durack DT. Experimental bacterial endocarditis. IV. Structure and funtion of very early lesions. J Pathol 1975;115:81.
  83. Durack DT, Beeson PB. Experimental bacterial endocarditis. I. Colonization of a sterile vegetation. Br J Exp Pathol 1972;53:44.
  84. Durack DT, Beeson PB, Petersdorf RG. Experimental endocarditis. III. Production and progress of the disease in rabbits. Br J Exp Pathol 1973;54:142.
  85. Gibbons RJ, Nygaard M. Synthesis of insoluble dextran and its significance in the formation of gelatinous deposits by plaque-forming streptococci. Arch Oral Biol 1968;13:1249.
  86. Burnette-Curley D, Wells V, Viscount H, Munro CL, Fenno JC, Fives-Taylor P, et al. FimA, a major virulence factor associated with Streptococcus parasanguis endocarditis. Infect Immun 1995;63(12):4669-74.
  87. Kuypers JM, Proctor RA. Reduced adherente to traumatized rat heart valves by a low-fibronectin-binding mutant of Staphylococcus aureus. Infect Immun 1989;57:2306.
  88. Lowrance JH, Baddour LM, Simpsom WA. The role of fibronectin binding in the rat model of experimental endocarditis caused by Streptococcus sanguis. J Clin Invest 1990;86:7.
  89. Sommer P, Gleyzal C, Guerret S, Etienne J, Grimaud JA. Induction of a putative laminin-binding protein of Streptococcus gordonii in human infective endocarditis. Infect Immun 1992;60(2):360-5.
  90. Becker RC, DiBello PM, Lucas FV. Bacterial tissue tropism: An in vitro model for infective endocarditis. Cardiovasc Res 1987;21:813-20.
  91. Tart RC, van de Rijn I. Análisis of adherente of Streptococcus defectivus and endocarditis-associated streptococci to extracellular matriz. Infect Immun 1991;59:857.
  92. Devitt D, Francois P, Vaudaux P, Foster TJ. Molecular characterization of te clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol Microbiol 1994;11:237-48.
  93. Entenza JM, Foster TJ, Ni Eidhin D, Vaudaux P, Francioli P, Moreillon P. Contribution of clumping factor B to pathogenesis of experimental endocarditis due to Staphylococcus aureus. Infect Immun 2000;68(9):5443-6.
  94. Moreillon P, Entenza JM, Francioli P, McDevitt D, Foster TJ, Francois P, et al. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis.Infect Immun 1995;63(12):4738-43.
  95. Que YA, Francois P, Haefliger JA, Entenza JM, Vaudaux P, Moreillon P. Reassessing the role of Staphylococcus aureus clumping factor and fibronectin-binding protein by expression in Lactococcus lactis. Infect Immun 2001;69(10):6296-302.
  96. Bayer AS, Ramos MD, Menzies BE, Yeaman MR, Shen AJ, Cheung AL. Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: a host defense role for platelet microbicidal proteins. Infect Immun 1997;65(11):4652-60.
  97. Herzberg MC, Brintzenhofe KL, Clawson CC. Aggregation of human platelets and adhesion of Streptococcus sanguis. Infect Immun 1983;39(3):1457-69.
  98. Herzberg MC, MacFarlane GD, Gong K, Armstrong NN, Witt AR, Erickson PR, et al. The platelet interactivity phenotype of Streptococcus sanguis influences the course of experimental endocarditis. Infect Immun 1992;60(11):4809-18.
  99. Herzberg MC, Gong K, MacFarlane GD, Erickson PR, Soberay AH, Krebsbach PH, et al. Phenotypic characterization of Streptococcus sanguis virulence factors associated with bacterial endocarditis. Infect Immun 1990;58(2):515-22.
  100. Herrmann M, Hartleib J, Kehrel B, Montgomery RR, Sixma JJ, Peters G. Interaction of von Willebrand factor with Staphylococcus aureus. J Infect Dis 1997;176(4):984-91.
  101. Hartleib J, Kohler N, Dickinson RB, Chhatwal GS, Sixma JJ, Hartford OM, et al. Protein A is the von Willebrand factor binding protein on Staphylococcus aureus. Blood 2000;96(6):2149-56.
  102. Leborgne J, Guiberteau-Canfrere V, Lehur PA, Bitar O, Remadi JP, Raffi R, et al. Problems posed by the association of streptococcus D infectious endocarditis and colorectal tumor. Chirurgie 1992;118(3):177-82. French.
  103. Demolombe-Rague S, Pinede L, Duhaut P, Ninet J, Pasquier J. Clinical aspects of infectious endocarditis in internal medicine. Apropos of 40 cases. Rev Med Interne 1993;14(10):1030. French.
  104. Koster R, Kahler J, Franzen O, Munzel T, Hamm CW. Diagnosis and therapy of infectious endocarditis. What measures are required?. MMW Fortschr Med 2002;144(14):28-34. German.
  105. Tamarchenko IP, Komarov VT. Systemic lupus erythematosus and infectious endocarditis: similarities and differences. Ter Arkh 2002;74(4):39-42. Russian.
  106. Johnson JD, Raff MJ, Barnwell PA, Chun CH. Splenic abscess complicating infectious endocarditis. Arch Intern Med 1983;143(5):906-12.
  107. Chou YH, Hsu CC, Tiu CM, Chang T. Splenic abscess: sonographic diagnosis and percutaneous drainage or aspiration. Gastrointest Radiol 1992;17(3):262-6.
  108. Le TH, Wechsler B, Cabane J, Herson S, Godeau P, Chomette G. Abscess splenic and infectious endocarditis. Arch Intern Med 1984;144(2):414.
  109. Le Thi Huong D, Wechsler B, Cabane J, Herson S, Godeau P, Chomette G. Splenic involvement in infectious endocarditis. 5 clinical cases and 78 necropsies. Ann Med Interne (Paris) 1984;135(3):181-8. French.
  110. Jorge Sdo C, Medeiros CS, Scuracchio PS, Assef JE, Arnoni AS, Sousa JE. Meningitis and other neurological complications in infectious endocarditis. Arq Bras Cardiol 1992;59(5):379-83. Portuguese.
  111. Tiurin VP, Odinak MM, Klimov IA, Kovalenko PA, Eliashevich VL. Neurological complications of infectious endocarditis. Klin Med (Mosk) 2002;80(2):27-31. Russian.
  112. Anguita M, Romo E, Vinals M, Ostos J, Bueno G, Vivancos R, et al. The management by medical treatment of an intracranial mycotic aneurysm in a patient with infectious endocarditis with negative blood cultures and hypertrophic myocardiopathy. Rev Esp Cardiol 1991;44(8):556-9.
  113. Eisert J. Skin manifestations of subacute bacterial endocarditis. Case report of subacute bacterial endocarditis mimicking Tappeiner's angioendotheliomatosis. Cutis 1980;25(4):394-5, 400.
  114. Young JB, Will EJ, Mulley GP. Splinter haemorrhages: facts and fiction. J R Coll Physicians Lond 1988;22(4):240-3.
  115. Ling R, James B. White-centred retinal haemorrhages (Roth spots). Postgrad Med J 1998;74(876):581-2.
  116. Espinosa Parra FJ, Ramos Rincon JM, Herrero Huerta F, Pretel Serrano L, Lorenzo AA. Diagnostic utility of Osler's nodules in infectious endocarditis among parenteral drug users. An Med Interna 2002;19(6):299-301.
  117. Kobayashi H, Sugiuchi R, Tabata N, Ninomiya M, Oumi M, Sadahiro M, et al. Guess what! Acute infectious endocarditis with Janeway lesions in a patient with atopic dermatitis. Eur J Dermatol 1999;9(3):239-40.
  118. Akopian LM, Kazanchian PO, Zhadovskaia VM, Mokachev II, Tailyev S. Infectious endocarditis with mycotic aneurysm and recurrent thromboembolism (successful surgical treatment). Ter Arkh 1986;58(10):54-6. Russian.
  119. Hermans PE. The clinical manifestations of infective endocarditis. Mayo Clin Proc 1982;57(1):15-21.
  120. Peruzzi G, Tallarida G, Baldoni F, Valesini G, Raimondi G, Massaro M, et al. Pathogenetic and clinical aspects of renal failure in infectious endocarditis. Recenti Prog Med 1982;73(2):120-56. Italian.
  121. Kitamura T, Shibata M, Isaka N, Nakano T. An elderly patient with infectious endocarditis complicated with congestive heart failure due to mitral and tricuspid regurgitation. J Cardiol 1997;29 Suppl 2:S131-S5. Japanese.
  122. Goldman ME, Fisher EA, Winters S, Reichstein R, Stavile K, Gorlin R, et al. Early identification of patients with native valve infectious endocarditis at risk for major complications by initial clinical presentation and baseline echocardiography. Int J Cardiol 1995;52(3):257-64.
  123. Diadyk AI, Vasilenko IV, Tsyba IN, Bagrii AE, Khomenko MV, Shpilevaia NI:The prognosis of the nature of the course and outcome of infectious endocarditis. Ter Arkh 1994;66(4):44-6. Russian.
  124. Diadyk AI, Tsyba IN, Vasilenko IV, Shpilevaia NI, Bagrii AE, Khomenko MV, et al: The clinico-morphological characteristics of glomerulonephritis in infectious endocarditis. Lik Sprava 1995;(3-4):88-92. Russian.
  125. Wurker M, Szelies B, Heindel W, Bohm M, Fischbach R, Heiss WD: Mycotic aneurysm in endocarditis lenta as the etiology of intraparenchymatous cerebral hemorrhage. Med Klin 1998;93(5):307-10. German.
  126. Choi HK, Lamprecht P, Niles JL, Gross WL, Merkel PA: Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies. Arthritis Rheum 2000;43(1):226-31.
  127. Rudolph W, Kraus F: Detection and evaluation of infectious endocarditis. Herz 1983;8(5):241-70. German.
  128. Varettas K, Taylor PC, Mukerjee C: Determination of the optimum incubation period of continuously monitored blood cultures from patients with suspected endocarditis or fungaemia. Pathology 2002;34(2):167-9.
  129. Pazin GJ, Saul S, Thompson ME: Blood culture positivity: suppression by outpatient antibiotic therapy in patients with bacterial endocarditis. Arch Intern Med 1982;142(2):263-8.
  130. Besnier JM, Choutet P: Methods and monitoring of antibiotic therapy of infectious endocarditis. Rev Prat 1998;48(5):513-8. French.
  131. Washington JA 2nd. The role of the microbiology laboratory in the diagnosis and antimicrobial treatment of infective endocarditis. Mayo Clin Proc 1982;57(1):22-32.
  132. Vaneeva NP, Tsvetkova NV, Gudkova RG, Deriabin PN: Diagnosis of staphylococcal diseases using an immunoenzyme reaction. Zh Mikrobiol Epidemiol Immunobiol 1984;(6):61-4. Russian.
  133. Decoodt P. Role of transesophageal echocardiography in infectious endocarditis. Rev Med Brux 2002;23(5):429-34. French.
  134. Korneev NV, Tiurin VP, Chernov MIu, Derevianko OR, Savina LN, Pestova AB:. Transesophageal echocardiography in diagnosis of infectious endocarditis. Klin Med (Mosk) 1999;77(5):21-4. Russian.
  135. Pena FJ, Banzo I, Quirce R, Vallina NK, Hernandez A, Guede C, et al:. Ga-67 SPECT to detect endocarditis after replacement of an aortic valve. Clin Nucl Med 2002;27(6):401-4.
  136. Gratz S, Raddatz D, Hagenah G, Behr T, Behe M, Becker W: 99mTC-labelled antigranulocyte monoclonal antibody FAB' fragments versus echocardiography in the diagnosis of subacute infective endocarditis. Int J Cardiol 2000;75(1):75-84.
  137. Lode H, Schaberg T, Hoffken G, Schroder R: Clinical aspects of endocarditis. Immun Infekt 1991;19(2):42-4. German.
  138. Julander I. Misinterpreted symptoms. Delayed diagnosis of endocarditis. Lakartidningen 1992;89(13):1069-70. Swedish.
  139. Misteli M, Conen D: Infectious endocarditis: reasons for a delayed diagnosis. Schweiz Med Wochenschr 1991;121(22):826-31. German.
  140. Durack DT, Lukes AS, Bright DK: New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994;96(3):200-9.
  141. Gilbert DN, Moellering RC, Sande MA, editors:. The Sanford guide to antimicrobial therapy 2002. 32th ed. USA: Antimicrobial Therapy Inc.; 2002. p. 18-9.
  142. Serrano Peña: J. Profilaxis de endocarditis bacteriana. Disponible en: www.fisterra.com/guias2/profilaxis_endocarditis.htm
  143. Tratamiento antibiótico de las endocarditis infecciosas. Disponible en: http://www.infecto.edu.uy/terapeutica/guiaatb/endoi.html
  144. Tratamiento médico de la endocarditis infecciosa. En: Rev Arg Cardiol 2002;70:21-41. Disponible en: http://www.sadi.org.ar/Tto_Medico.pdf
  145. Malinverni R: Aminoglycosides in the treatment of infectious endocarditis. Schweiz Med Wochenschr 1996;76(Suppl):S14-S20. German.
  146. Braselli A: Endocarditis infecciosa. Disponible en: http://www.infecto.edu.uy/indicefrpbreves.html
  147. Kondo N, Ono Y, Onozuka N, Koyama M, Fukui K, Takaya S, et al: Surgical treatment of infectious endocarditis complicated by discrete subaortic stenosis: report of a case. Kyobu Geka 2001;54(9):777-9. Japanese.
  148. Ben Ameur Y, Haouala H, Fehri W, Rahal N, Mhenni H, Guediche M. Coxiella: burnetti infectious endocarditis. Apropos of a case. Ann Cardiol Angeiol (Paris) 1997;46(10):671-3. French.
  149. Kupferwasser LI, Yeaman MR, Shapiro SM, Nast CC, Sullam PM, Filler SG, Bayer AS: Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects. Circulation 1999;99(21):2791-7.
  150. Marks KA, Zucker N, Kapelushnik J, Karplus M, Levitas A: Infective endocarditis successfully treated in extremely low birth weight infants with recombinant tissue plasminogen activator. Pediatrics 2002;109(1):153-8.